TET2 and chronic myelomonocytic leukemia: Interestingly, such aberrant DNA methylation profile detected in TET2-mutated CMML patient samples was significantly enriched outside CpG islands, which overlap with enhancer regulatory regions enriched for PU.1 transcription factor and p300 regulatory complex (Figure 2C), as was further validated in different studies [86,87,88].